SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-003938
Filing Date
2017-01-25
Accepted
2017-01-25 10:06:05
Documents
6
Period of Report
2017-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-3186_18k.htm 8-K 25249
2 EX-99.1 a17-3186_1ex99d1.htm EX-99.1 14681
3 GRAPHIC g31861mmi001.jpg GRAPHIC 2783
4 GRAPHIC g31861mmi002.jpg GRAPHIC 2784
5 GRAPHIC g31861mmi003.jpg GRAPHIC 2783
6 GRAPHIC g31861mmi004.jpg GRAPHIC 2783
  Complete submission text file 0001104659-17-003938.txt   57027
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 17545215
SIC: 2834 Pharmaceutical Preparations